AGATA
Biomarker Program
SOLTI Molecular screening platform: a Pilot Study to implement personalized therapy for patients with advanced or metastatic breast cancer (MBC).
Phase 0
Status
Finished
Tumour subtype:
Biomarker driven
Scenario
Locally Advanced or Metastatic
SPONSOR
COLLABORATORS
PRINCIPAL INVESTIGATORS
Eva Mª Ciruelos Gil , MD, PhD (Hospital 12 de Octubre, Madrid)
Sònia Pernas Simón, MD ICO (L’Hospitalet, Barcelona)
Sites
HOSPITAL ARNAU DE VILANOVA DE VALENCIA, HOSPITAL CLINIC DE BARCELONA, HOSPITAL CLÍNICO UNIVERSITARIO DE VALENCIA, HOSPITAL UNIVERSITARI VALL D’HEBRON, HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, HOSPITAL UNIVERSITARIO MADRID SANCHINARRO (CENTRO INTEGRAL ONCOLÓGICO CLARA CAMPAL (CIOCC)), HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO, ICO GIRONA (HOSPITAL DR. JOSEP TRUETA), ICO HOSPITALET (DURAN I REYNALS)
